Joseph Romanelli - 02 Dec 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Signature
/s/ Jon Filderman, attorney-in-fact for Joseph Romanelli
Issuer symbol
MRK
Transactions as of
02 Dec 2022
Net transactions value
+$40,673
Form type
4
Filing time
30 Jun 2023, 16:04:51 UTC
Previous filing
26 Jul 2022
Next filing
16 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRK Common Stock Purchase $6,471 +59 $109.67 59 02 Dec 2022 By Spouse F1
transaction MRK Common Stock Purchase $11,721 +107 +0.53% $109.54 20,391 05 Dec 2022 Direct F1
transaction MRK Common Stock Purchase $3,282 +30 +0.15% $109.39 20,421 06 Dec 2022 Direct F1
transaction MRK Common Stock Purchase $6,214 +56 +0.27% $110.96 20,477 13 Dec 2022 Direct F1
transaction MRK Common Stock Purchase $763 +7 +0.03% $109.04 20,484 19 Dec 2022 Direct F1
transaction MRK Common Stock Purchase $1,201 +11 +0.05% $109.20 20,495 21 Feb 2023 Direct F1
transaction MRK Common Stock Purchase $14,344 +136 +0.66% $105.47 20,631 20 Mar 2023 Direct F1
transaction MRK Common Stock Sale $3,663 -35 -0.17% $104.65 20,596 24 Mar 2023 Direct F1
transaction MRK Common Stock Purchase $341 +3 +0.01% $113.68 20,599 26 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 None of the purchases or sales reported herein were directed by the reporting person, but were executed by a brokerage firm for the benefit of the reporting person's managed account, without the reporting person's knowledge. One of the reported transactions resulted in a short swing profit under Section 16(b) of the Securities Exchange Act of 1934, as amended ("Section 16(b)"), and the reporting person has disgorged $374.01 to the Issuer, which amount represents all profits related to these transactions in accordance with Section 16(b).